Aplagon Raises €7 Million in Equity Funding
Aplagon, a Finland-based clinical-stage biopharmaceutical company, raised €7 million in equity funding. The funding round was co-led by new investors Fahraeus Startup and Growth AB … Read more…
Aplagon, a Finland-based clinical-stage biopharmaceutical company, raised €7 million in equity funding. The funding round was co-led by new investors Fahraeus Startup and Growth AB … Read more…